Action of hallucinogens on raphe-evoked dorsal root potentials (DRPs) in the cat.
A A Larson, E G Anderson
Pharmacology, Biochemistry, and Behavior February 1, 1986 DOI: 10.1016/0091-3057(86)90364-3 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study Peer reviewed |
|---|---|
| Population | Cats |
| Interventions | LSD 5-methoxy-N N-dimethyltryptamine (5-MeODMT) ketamine phencyclidine (PCP) tryptophan fluoxetine parachlorophenylalanine reserpine 5 7-dihydroxytryptamine |
| Key findings | The raphe-evoked dorsal root potential may be mediated at least in part by a non-serotonergic transmitter. |
Abstract
The dorsal root potential (DRP) evoked by stimulation of the inferior central nucleus (ICN) of the cat is affected by administration of a variety of hallucinogenic agents. It has been previously shown that a single low dose of LSD is unique in that it potentiates this DRP, while injections of 5-methoxy-N,N- dimethyltryptamine (5-MeODMT), ketamine or phencyclidine (PCP) inhibit its production. Tolerance develops to the facilitatory effect of low doses of LSD on the DRP, but not to the inhibitory action of 5-MeODMT. Repeated injections of ketamine every 30 minutes also fail to produce tachyphylaxis to the inhibitory effect of this dissociative anesthetic. The raphe-evoked DRP is a long latency potential that is inhibited by a wide variety of putative serotonin antagonists and has therefore been traditionally thought to be mediated by serotonin. However, in light of the inability of either tryptophan or fluoxetine to potentiate this DRP, and the resistance of this DRP to blockade by parachlorophenylalanine, reserpine or intrathecally administered 5,7-dihydroxytryptamine, it appears that this potential may in fact be mediated, at least in part, by a non-serotonergic transmitter.
Citations in the library
Cites 5
- CLINICAL REACTIONS AND TOLERANCE TO LSD IN CHRONIC SCHIZOPHRENIA The Journal of Nervous and Mental Disease September 1, 1955
- THE PRESERVATION OF SUBSTANCE P BY LYSERGIC ACID DIETHYLAMIDE British Journal of Pharmacology and Chemotherapy September 1, 1957
- Development of tolerance to repeated administration of 5-methoxy-N,N-dimethyltryptamine in rats. European Journal of Pharmacology January 15, 1985
- POTENTIATION OF SUBSTANCE P BY LYSERGIC ACID DIETHYLAMIDE IN VIVO British Journal of Pharmacology and Chemotherapy 1961
- Acute and chronic effects of LSD and 5-MeODMT on raphe-evoked dorsal root potentials in the cat. Life Sciences March 19, 1984